Bone marrow-derived cells are the major source of MMP-9 contributing to blood–brain barrier dysfunction and infarct formation after ischemic stroke in mice
- 6 October 2009
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1294, 183-192
- https://doi.org/10.1016/j.brainres.2009.07.070
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Filamentous Middle Cerebral Artery Occlusion Causes Ischemic Damage to the Retina in MiceStroke, 2008
- Reperfusion activates metalloproteinases that contribute to neurovascular injuryExperimental Neurology, 2008
- Serum Cellular Fibronectin and Matrix Metalloproteinase-9 as Screening Biomarkers for the Prediction of Parenchymal Hematoma After Thrombolytic Therapy in Acute Ischemic StrokeStroke, 2007
- Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokinesAmerican Journal of Physiology-Cell Physiology, 2006
- Astrocytic Induction of Matrix Metalloproteinase-9 and Edema in Brain HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2006
- A role for bone marrow–derived cells in the vasculature of noninjured CNSBlood, 2005
- Matrix Metalloproteinase-9 and Myeloperoxidase ExpressionStroke, 2004
- Neutrophil Infiltration Increases Matrix Metalloproteinase-9 in the Ischemic Brain after Occlusion/Reperfusion of the Middle Cerebral Artery in RatsJournal of Cerebral Blood Flow & Metabolism, 2003
- Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic StrokeStroke, 2001
- Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats.Stroke, 1994